Walgreens Boots Alliance Inc (WBA) Shares Bought by Schaper Benz & Wise Investment Counsel Inc. WI

Schaper Benz & Wise Investment Counsel Inc. WI raised its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 0.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 235,355 shares of the pharmacy operator’s stock after acquiring an additional 920 shares during the period. Walgreens Boots Alliance makes up approximately 2.3% of Schaper Benz & Wise Investment Counsel Inc. WI’s investment portfolio, making the stock its 11th largest position. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Walgreens Boots Alliance were worth $17,157,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. GSA Capital Partners LLP acquired a new stake in shares of Walgreens Boots Alliance in the first quarter valued at approximately $231,000. Rainier Group Investment Advisory LLC raised its position in shares of Walgreens Boots Alliance by 35.7% in the first quarter. Rainier Group Investment Advisory LLC now owns 3,800 shares of the pharmacy operator’s stock valued at $249,000 after buying an additional 1,000 shares in the last quarter. Private Capital Group LLC raised its position in shares of Walgreens Boots Alliance by 1,027.6% in the first quarter. Private Capital Group LLC now owns 3,225 shares of the pharmacy operator’s stock valued at $211,000 after buying an additional 2,939 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its position in shares of Walgreens Boots Alliance by 270.3% in the first quarter. Massmutual Trust Co. FSB ADV now owns 21,721 shares of the pharmacy operator’s stock valued at $1,422,000 after buying an additional 15,856 shares in the last quarter. Finally, Summit Trail Advisors LLC raised its position in shares of Walgreens Boots Alliance by 5,702.1% in the first quarter. Summit Trail Advisors LLC now owns 170,291 shares of the pharmacy operator’s stock valued at $170,000 after buying an additional 167,356 shares in the last quarter. Institutional investors own 61.96% of the company’s stock.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total transaction of $180,548.64. Following the completion of the transaction, the director now directly owns 10,943 shares in the company, valued at $722,128.57. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 14.80% of the stock is owned by insiders.

A number of equities research analysts have recently weighed in on WBA shares. Pivotal Research lifted their price target on shares of Walgreens Boots Alliance from $60.00 to $72.00 and gave the company a “hold” rating in a research report on Monday. Loop Capital lifted their price target on shares of Walgreens Boots Alliance to $80.00 and gave the company a “buy” rating in a research report on Friday, June 29th. Mizuho downgraded shares of Walgreens Boots Alliance from a “buy” rating to a “neutral” rating and set a $64.00 price target for the company. in a research report on Monday, July 2nd. TheStreet upgraded shares of Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research report on Wednesday, September 12th. Finally, Citigroup downgraded shares of Walgreens Boots Alliance from a “buy” rating to a “neutral” rating and set a $69.00 price target for the company. in a research report on Monday, July 9th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $78.22.

WBA traded up $0.76 during trading on Friday, hitting $77.34. 471,801 shares of the stock traded hands, compared to its average volume of 6,372,291. Walgreens Boots Alliance Inc has a twelve month low of $59.07 and a twelve month high of $80.68. The company has a market cap of $73.07 billion, a P/E ratio of 12.92, a P/E/G ratio of 1.16 and a beta of 1.04. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, beating the consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. The business had revenue of $33.44 billion during the quarter, compared to the consensus estimate of $33.64 billion. On average, analysts expect that Walgreens Boots Alliance Inc will post 6.53 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

See Also: Return on Investment (ROI) Defined, Explained

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply